Context:The Proseal LMA(PLMA), which has been designed especially for positive pressure ventilation and protection against aspiration can act as an alternative to Endotracheal Tube (ETT) as an effective airway device for patients undergoing elective Laparoscopic surgeries.Aims:To compare the efficacy and safety of PLMA with ETT in patients undergoing Laparoscopic surgeries under general anaesthesia.Settings and Design:A prospective, randomized study was conducted in a tertiary care teaching hospital with 60 patients of ASA grade I/II undergoing elective Laparoscopic surgery under general anaesthesia. Ethical committee clearance and written consent taken. The patients were randomly divided into two equal groups to the PLMA group (Group S) and to the ETT group (Group C) Heart rate (HR), mean blood pressure (MAP), ETCO2 values, intraoperative complications such as regurgitation- aspiration, and Postoperative complications such as nausea or vomiting, throat soreness and oral injuries were monitored.Results:There was no difference demographically. Insertion success rate was 100% for both the groups. The mean increase in HR was seen all throughout the duration of the surgery to 8 % above the baseline in Group C and to 3% above the baseline in Group S. On comparing the MAP in Group C, there was a increased by 2.5% to 78.300 ± 14.2615 mmHg as compared to an increase by 5% to 76.233 ± 6.2072 mmHg in Group S. EtCO2 showed a rise in both groups after pneumoperitoneum, which returned to baseline values after completion of surgery. Gastric aspirate values showed no difference in each group. Post op complications were seen mainly in Group C with statistical significance.Conclusions:A properly positioned PLMA is a suitable and safe alternative to ETT for airway management in adequately fasted, adult patients undergoing elective Laparoscopic surgeries.
Background:Shivering is a common problem in patients undergoing surgery under spinal anesthesia.Aims:The aim of this study was to compare efficacy and safety of clonidine versus tramadol in postspinal anesthesia shivering.Settings and Design:This prospective, randomized, double-blind controlled clinical trial was conducted in a tertiary care setting.Materials and Methods:A total of 60 American Society of Anesthesiologists physical status Class l and II adult patients (age 18–65 years) undergoing surgery under spinal anesthesia and developed shivering received either clonidine 1 μg/kg or tramadol 1 mg/kg intravenously. The time required for cessation of shivering, control and recurrence rate of shivering, effect on hemodynamics and side effects were compared between two groups.Statistical Analysis:Unpaired t-test and Chi-square test were used for comparison of continuous variables and dichotomous data between two groups, respectively. P < 0.05 was considered as statistically significant.Results:Time for cessation of shivering was less in clonidine group than tramadol group (02.51 vs. 04.82 min; P < 0.001). Complete control of shivering was achieved in 80% of patients in clonidine group versus 70% in tramadol group. There was no significant difference for control (P = 0.5) and rate of recurrence of shivering between clonidine and tramadol group (06.7% vs. 16.7%; P = 0.42). Pulse rate and systolic blood pressure were significantly lower in clonidine group at 5 and 15 min as compared with tramadol. Significantly more number of patients experienced nausea and dizziness (36.7% vs. 0%; P < 0.001 and 20% vs. 0%; P = 0.01) with tramadol while bradycardia and hypotension were numerically more common in patients receiving clonidine (6.7% vs. 0% and 13.3% vs. 0%).Conclusion:Clonidine provides early relief from shivering than tramadol with fewer side effects in patients undergoing surgery under spinal anesthesia.
Background and Aims:Supraclavicular brachial plexus block is ideal for upper limb surgical procedures. Buprenorphine, an agonist antagonist opioid has been used as an adjunct to prolong analgesia. We aimed to evaluate the quality and duration of postoperative analgesia by addition of buprenorphine to local anesthetic solution.Material and Methods:A prospective, randomized, double-blind control study was conducted on 50 healthy patients of ASA Grade I/II of age group 20-70 years scheduled for orthopedic and reconstructive surgery of upper limb under supraclavicular brachial plexus block. Patients were allocated into two groups, 25 in each group viz.: Group B (buprenorphine group) received 20 ml 0.5% bupivacaine + 15 ml 2% lignocaine with adrenaline (1:200,000) + 4 ml normal saline + 1500 units hyaluronidase + 3 μg/kg buprenorphine diluted to 1 ml normal saline. Group C (control group) received 20 ml 0.5% bupivacaine + 15 ml 2% lignocaine with adrenaline (1:200,000) + 4 ml normal saline + 1500 units hyaluronidase + 1 ml normal saline. The parameters observed were onset and duration of sensory and motor block, quality and duration of analgesia and side-effects.Results:The mean duration of postoperative analgesia was significantly longer in Group B (16.04 ± 3.19 h) than in Group C (6.20 ± 0.74 h). There was no difference between two groups on mean onset of sensory block. The mean duration motor block was significantly longer in Group B (4.93 ± 0.94 h) than in Group C (2.25 ± 0.62 h) [P < 0.05]. The mean duration of sensory block was also significantly longer in Group B (5.71 ± 0.94 h) than in Group C (4.94 ± 0.70 h) with P < 0.05.Conclusion:Addition of 3 μg/kg buprenorphine to 0.5% bupivacaine for supraclavicular brachial plexus block prolonged duration of postoperative analgesia and sensory blockade without an increase in side effects.
Co Induction Agents for LMA. BACKGROUND: A randomized double blind comparative study was done to assess the effectiveness of fentanyl & butorphanol as coinduction agents with propofol for insertion of Laryngeal Mask Airway (LMA) in adults for elective short surgical procedures. METHODS: Sixty patients of ASA grade 1 and 2 between 15-55 years of age were randomly divided into two groups. After giving standard premedication group A was given injection butorphanol 20 mcg/kg IV and group B injection fentanyl 1.5mcg/kg IV. Both the groups were immediately given propofol 2.5mg/kg IV over 15 seconds until loss of eyelash reflex, after which LMA insertion was performed 60 seconds after injection of propofol. Patients were kept on spontaneous respiration and maintained with isoflurane 0.5%-1.2%, 60%N2O, and 40%O2 along with propofol bolus when required. RESULTS: In our study propofol requirement for LMA insertion was significantly less in butorphanol group and significantly less apnea time was seen with butorphanol (96.66%) as compared to fentanyl (76.66%). The incidence of absolute jaw relaxation was highest in butorphanol (93.33%) and excellent insertion conditions were observed. Best insertion conditions were seen in 92.30% of butorphanol group and 74.15% in fentanyl group. CONCLUSION: The addition of butorphanol to propofol for LMA insertion provides good jaw relaxation and excellent LMA insertion conditions with stable haemodynamics. Side effects like coughing, gagging, lacrimation, and limb movements are lower as compared to the other group. So, butorphanol is a good adjuvant with propofol for LMA insertion during short surgical procedures under general anesthesia.
Background and Aims: Resilience of healthcare professionals involved in Anesthesia practice is relatively a new area of research. Improvement of resilience is important for the sustainability of the healthcare workforce. The aim of this study was to evaluate resilience of the health care providers towards intra-operative emergency situation and intensive care unit. Material and Methods: In this cross-sectional pilot study, healthcare providers working involved in anesthesia practice responded to a questionnaire consisting of 20 questions related to their regular work profile. Answers were graded as- ”Yes”, “Not often” and “No”. Scores of “Three”, “Two” and “One” were assigned to these responses and total score was calculated. Frequency and percentage of each response were compared based on place of work and roles. Scores were compared based on the designation. Results: Out of 103 healthcare workers 56 (54.4%) were from government or charity hospital. Thirty-one (30.1%) were Junior Residents. Comparison of responses based on the role/designation, significant differences were observed for questions- I reach to operation theatre well before the proposed time for the case (0.02994), I personally check operation theatre preparation (p = 0.01966), I check for the consent form every time (p = 0.02018), I can recognize different electrocardiogram (ECG) patterns (p = 0.00231) and I always try to learn from everything (p = 0.01989). Based on the place of work of study participants, there was a significant difference (p = 0.002095) for question, i.e., “I personally check operation theatre preparation.” Conclusion: The study results suggested good resilience of healthcare professionals involved in anesthesia and intensive care. Some pointers towards burnout are seen among study population. Early interventions may be useful to improve resilience and reduce risk of burnout.
Systemic lupus erythematosus (SLE) is an autoimmune disease most frequently found in women of child bearing age and may co-exist with pregnancy. Disease exacerbation, increased foetal loss, neonatal lupus and an increased incidence of pre-eclampsia are the major challenges. Its multisystem involvement and therapeutic interventions like anticoagulants, steroids and immunosuppressive agents pose a high risk for both surgery and anaesthesia. We describe successful management of an antinuclear antibody (ANA) positive parturient with bad obstetric history who underwent elective caesarean section under spinal anaesthesia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.